MedTrace Logo

The Impact of Migraine on Canadians' Productivity: A Real-World Pharmacy-Based Study

NCT05556564 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-04-21

No results posted yet for this study

Summary

This is a cross-sectional, real-world observational, community pharmacy-based study in which adults treated with a triptan for their migraine will self-report productivity and activity impairment using a web-based portal or paper-based questionnaire.

Conditions

Interventions

DRUG

observational study

No intervention, observational study

Sponsors & Collaborators

  • PeriPharm

    lead OTHER

Principal Investigators

  • Jean Lachaine · PeriParm inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2023-03-06
Completion
2023-03-06

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05556564 on ClinicalTrials.gov